2-(2-Chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

Methyl 3,3-difluorocyclobutanecarboxylate, 95.0%, 500g

(E)-Methyl 3-(4-cyano-3-methoxyphenyl)acrylate, 250mg

(S)-2-(4,5-DIHYDRO-4-ISOPROPYL-2-OXAZOLYL)QUINOLINE, 98%, 5g

tert-Butyl 2-isobutylpiperazine-1-carboxylate, 95.0%, 250mg

1H-Indol-4-amine, 98.0%, 5g

3-Hydroxybenzaldéhyde, min 97 %, pour la synthèse, 250 g, emballage plastique.

2-(3-CHLORO-4-CYCLOPROPYLPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95%, 1g

tert-Butyl N-[3-(iodomethyl)oxetan-3-yl]carbamate, 98%, 1g

2,2,4,4,6,6-Hexamethyl-1,3,5-trithiane, 95.0%, 5g

6-Methyl-1H-pyrazolo[3,4-b]pyridine, 98%, 250mg

ALMITRINE DIMESYLATE, 99%, 25g

2'-Methyl-2,2,2-trifluoroacetophenone, 97.0%, 1g